Insight Molecular Diagnostics (IMDX) EBT Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) EBT Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -161.54% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 7.04% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 9.39% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 14.63% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -27.03% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 56.92% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 1.55% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -13.74% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 3.82% |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | 35.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.09% |
| Dec 31, 2025 | 16.81% |
| Sep 30, 2025 | 18.25% |
| Jun 30, 2025 | -112.48% |
| Mar 31, 2025 | 25.52% |
| Dec 31, 2024 | 191.76% |
| Sep 30, 2024 | -108.28% |
| Jun 30, 2024 | 44.41% |
| Mar 31, 2024 | -253.20% |
| Dec 31, 2023 | -33.08% |
| Sep 30, 2023 | -256.93% |
| Jun 30, 2023 | -510.92% |
| Mar 31, 2023 | 274.60% |
| Dec 31, 2022 | 66.42% |
| Sep 30, 2022 | 86.83% |
| Jun 30, 2022 | 88.90% |
| Mar 31, 2022 | 70.28% |
| Dec 31, 2021 | -453.31% |
| Sep 30, 2021 | -103.45% |
| Jun 30, 2021 | -34.90% |